Tubeimoside-1: An Updated Overview on Its Molecular Mechanisms and Medical Applications

Authors

  • Lanan Wassy Soromou Department of Applied Biology, University of Labé, 210 Labé, Republic of Guinea.
  • Mamadou Fodé Camara Department of Veterinary Medicine, Institute of Science and Veterinary Medicine, 09 Dalaba, Republic of Guinea.

DOI:

https://doi.org/10.9734/bpi/cops/v1/17195D

Keywords:

Tubeimoside-1, pharmacological activities, natural compounds

Abstract

Background: For many years, plant-derived agents are used in many medical areas. Tubeimoside-1 (TBMS1) is a triterpenoid saponin first isolated in China from Bolbostemma paniculatum (Maxim) Franquet, Cucurbitaceae.

Objectives: This chapter gives a thorough overview of TBMS1 and discusses its pharmacological activities in great detail.

Methodology: Peer-reviewed scientific articles were analyzed in this study.

Results: TBMS1 has generated a lot of interest in the medical community due to its wide range of pharmacological activities, including anticancer, anti-inflammatory, antitumor, antidiabetic, anti-human immunodeficiency virus, and neuroprotective effects.

Conclusion: In this study, TBMS1 displays several pharmacological effects through various mechanisms with a special emphasis on its medical application against diverse diseases. Despite having significant functionalities, more research is needed to expand the range of its applications.

Published

2022-12-24

How to Cite

Lanan Wassy Soromou, & Mamadou Fodé Camara. (2022). Tubeimoside-1: An Updated Overview on Its Molecular Mechanisms and Medical Applications. Current Overview on Pharmaceutical Science Vol. 1, 66–88. https://doi.org/10.9734/bpi/cops/v1/17195D

Issue

Current Overview on Pharmaceutical Science Vol. 1

Section

Chapters